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Summary 
The (R)- and (S)-optical isomers of 9 epoxides, benzyloxymethyloxirane, epichlorohydrin, glycidol, 
glycidyl 3-nitrobenzenesulfonate, glycidyl 4-nitrobenzoate, glycidyl tosylate, styrene oxide, glycidyl 1- 
naphthyl ether and glycidyl 4-nitrophenyl ether, have been compared for their in vivo and in vitro 
genotoxicity. The in vitro short-term test employed was the Ames mutagenicity assay with Salmonella 
strain TA100. The in vivo tests were chromosomal aberrations (CA) as well as sister-chromatid exchange 
(SCE) in bone-marrow cells of mice following intraperitoneal administration of these epoxides. Differ- 
ences in mutagenicity between isomers were established with TA100 for all the compounds. While 13 of 
the isomers were genotoxic compared to a negative control by CA measurements, only in the case of 
glycidyl 4-nitrobenzoate could a significant difference be found between isomers by this test. However, 
with SCE evaluations, differences were detected between the (R)- and (S)-isomers for all the pairs of 
compounds with the exception of those for benzyloxymethyloxirane and glycidyl 4-nitrophenyl ether. At 
least in part, differences in the patterns of genotoxicity among compounds can be related to their 
differences in reaction pathways. 
The reactivity of epoxides with nucleophiles and their derivatives have made them especially 
that forms the basis of their utility as chemical useful for this purpose. The synthesis and reactiv- 
intermediates could also lead to toxicity subse- ities of these nonracemic epoxides have recently 
quent to their reaction with bionucleophiles. The been reviewed by Hanson (1991). 
recent increased availability of enantiomeric The structures of the optical isomers under 
epoxides has promoted their use for the introduc- study in the present investigation for their geno- 
tion of stereocenters in complex molecules. The toxicity are shown in Table 1. The designation of 
commercial availability of (R)- and (S)-glycidol R and S to glycidol and its derivatives follows the 
nomenclature rules described by Prelog and 
Helmchen (1982). The application of these rules 
will, as shown in Table 1, result in opposite 
Correspondence: Dr. J.E. Sinsheimer, College of Pharmacy, ( R / S )  nomenclature for the same epoxide moiety 
University of Michigan, Ann Arbor, M! 48109-1065, USA. with different substituent groups. 
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TABLE 1 
STRUCTURES OF THE TEST COMPOUNDS 




i~ -- OCI-I 2 benzyloxymethyloxirane; (R)-( - ) (S)-( + ) 
(benzyl glycidyl ether) [14618-80-5] ~ [16495-13-9] 
2. CICH 2 epichlorohydrin; (S)-( + ) (R)-( - ) 
(1-chloro-2,3- [67843-74-7] [51594-55-9] 
epoxypropane) 
3. HOCH 2 glycidol (R)-( + ) (S)-( - ) 
[57044-25-4] [60456-23-7] 
4. ~ "  glycidyl 1-naphthyl (S)-(+) (R)-( ) 
OCH2 ether [61249-00-1] [56715-28-7] 
°2N o 
5. S--OCH2 glycidyl 3-nitro- (S)-( + ) (R)-( - ) 
benzenesulfonate [115314-14-2] [115314-17-5] 
O 
@ 1 1  glycidyl 4-nitro- (S)-( + ) (R)-( - ) 
6. O:~q C--OCH2 benzoate [115459-65-9] [106268-95-5] 
7. O I N ~ O C H  2 glycidyl 4-nitro- (S)-( + ) (R)-( - ) 
phenyl ether [125279-82-5] [125279-81-4] 
8. H 3 C - ' ~  _ _  / ~ ' -  s -  O C H 2 1 1  glycidyl tosylate (S)-( + ) (R)-( - ) 
o [70987-78-9] [113826-06-5] 
9. ~ styrene oxide; (R)-(+)  (S)-( ) 
(1,2-epoxyethylbenzene) [20780-53-4] [20780-54-5] 
a Chemical Abstracts Service registry numbers. 
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TABLE 2 
MUTAGENICITY OF EPOXIDE R AND S ISOMERS IN Salmonella typhimurium TA100 
Compounds R S 
Dose Revertants Rev//~mol a Revertants Rev/p.mol a 
(~mol) (mean _+ S.D.) (mean + S.D.) 
Benzyloxymet hyloxirane 
0 11l+ 16 260+_ 6 111+ 16 288+- 6 
0.05 116+- 11 107_+ 7 
0.1 123+- 13 124+ 10 
0.33 184_+ 24 196_+ 11 
0.66 265+- 51 289+- 35 
1 336_+ 20 344+ 19 
3 894_+ 43 982 + 23 
Epichlorohydrin 
0 90+- 14 208_+ 3 90_+ 14 161+- 3 
0.05 96_+ 6 113_+ 9 
0.1 110_+ 15 107+- 6 
0.2 119_+ 12 118_+ 14 
0.4 170_+ 10 164_+ 10 
0.8 248+- 22 232+- 20 
1.6 407_+ 31 356_+ 24 
3.2 760-+ 38 601-+ 13 
Glycidol 
0 145_+ 25 598_+ 13 145_+ 25 355_+ 14 
0.05 195_+ 31 156+- 25 
0.1 245_+ 13 185_+ 29 
0.2 306_+ 27 229_+ 18 
0.4 455 + 28 308 +- 20 
0.8 632_+ 86 426+- 59 
1.6 1131+ 46 717+-105 
Glycidyl 1-naphthyl ether 
0 126_+ 16 9268_+310 126_+ 16 8135+-229 
0.01 318+- 50 244_+ 22 
0.025 576+ 72 386+ 44 
0.05 899_+ 98 632_+ 86 
0.1 1329_+ 134 986_+ 113 
0.2 2041 +- 191 1782 + 242 
Glycidyl 3-nitrobenzenesulfonate 
0 119+- 7 661+- 8 119+- 7 1050_+ 23 
0.1 228_+ 33 296_+ 9 
0.33 373_+ 17 566+- 40 
0.66 580_+ 39 890+ 65 
l 820_+ 33 1239_+ 58 
2 1461+- 42 2263+-205 
Glycidyl 4-nitrobenzoate 
0 132+- 14 3883+- 99 132_+ 14 4674+- 79 
0.05 394-+ 18 398+- 20 
0.1 558+- 52 654+- 21 
0.2 941-+ 79 1 165 + 53 
0.4 1697 +- 169 2 013 +- 268 
0.8 3 276 + 372 3 907 + 176 
1.6 2 443 + 343 2 382 + 419 
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TABLE 2 (continued) 
Compounds R 
Dose Revertants Rev/p ,  mol ~' Revertants Rev/p ,  mol ~ 
(/z tool) (mean ± S.D.) (mean ± S.D.) 
Glycidyl 4-nitrophenyl ether 
0 124_+ 11 3099_+ 90 124_+ 11 2517+_ 63 
0.01 198_+ 27 172+ 23 
0.05 366+ 29 327± 23 
0.1 566+ 50 489_+ 57 
0.33 1219+156 1091+ 88 
0.66 2216_+264 1 799_+ 151 
Glycidyl tosylate 
0 144_+ 27 949_+37 144-+ 27 1969+132 
0.1 257+ 54 396+ 69 
0.33 439+_ 61 729± 15 
(/.66 799+ 190 1659-+ 218 
1 1031_+180 2408_+ 467 
2 2 239 -+ 218 3 997 + 1041 
3 2900+559  6135+2169  
Styrene oxide 
0 129+ 28 134+ 3 129+ 28 77_+ 3 
1 216-+ 19 180+ 11 
2 359+ 35 244-+ 13 
4 584+ 17 377+ 33 
6 972+ 79 592+ 86 
8 1146+ 36 717_+ 90 
Values are the calculated slopes of the linear portion of the dose-response curve determined by at least two independent 
experiments. 
As reviewed by Hanson (1991), the epoxides in genotoxic potencies of the test compounds should 
the present study can have a number of different be expected. 
modes of reaction with a nucleophile. While While there are numerous reports concerning 
glycidol and benzyloxymethyloxirane undergo the genotoxicity of the racemic forms of glycidol, 
ring opening through nucleophilic attack on C-3 epichlorohydrin and styrene oxide, previous stud- 
of an epoxide of the general structure, ies concerning differences in genotoxicity be- 
O tween the enantiomers in Table 1 are limited. 
1 2 /  ~ 3  
X - - C - - C  C, glycidyl benzenesulfonates Watabe et al. (1981) did not detect a difference 
are known to react at C-1 to result in a nucle- between styrene oxide isomers using Salmonella 
ophilic displacement of the sulfonate groups un- TA100 in the Ames procedure. However, Pagano 
der basic conditions (Klunder et al., 1989). et al. (1982) did find the (R)-isomer to be more 
Epichlorohydrin can react at C-1 (displacement) mutagenic than the (S)-isomer with TA100 and 
and undergo ring opening at C-3 (McClure et al., this was confirmed by Seiler (1990). Seiler also 
1979). Styrene oxide, on the other hand, gives presented evidence of qualitative differences in 
ring opening through nucleophilic attack at both D N A  binding between the isomers. Furthermore, 
its c~ and /3 carbons (Tamura et al., 1982). Gly- Hiratsuka et al. (1989) have shown that (R)- 
cidyl 4-nitrobenzoate can hydrolyze first to glyci- styrene oxide conjugates faster with glutathione 
dol and then undergo ring opening upon nucle- in rat-liver cytosol than the (S)-isomer while 
ophilic attack (Ko et al., 1987). Even if only these Watabe et al. (1981) have shown the (S)-isomer to 
factors are considered, a complex outcome of be the better substrate for rat-liver microsomal 
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hydrolase. Such differences in rates of detoxica- tions of the epoxides were measured and their 
tion could be a factor in explaining differences in purity examined by thin-layer chromatography. 
genotoxicity of (R)- and (S)-isomers in vivo. Re- The isomers of styrene oxide, glycidol and gly- 
cently, yon der Hude et al. (1992) completed a cidyl 4-nitrobenzoate required purification by 
study on the in vitro genotoxicity of the enan- chromatography over silica with hexane-ethyl ac- 
tiomers of glycidol, styrene oxide and glycidyl etate systems to remove impurities and to meet 
4-nitrobenzoate, compounds included in our their original optical specifications. The chart- 
study, as well as 9 additional pairs of related tiomers of glycidyl 1-naphthyl ether (4) and gly- 
enantiomeric epoxides. In their investigation of cidyl 4-nitrophenyl ether (7) were synthesized ac- 
the induction of sister-chromatid exchange (SCE) cording to the procedure of Klunder et al. (1989) 
frequencies with Chinese hamster V79 cells, sta- with (R)- or (S)-glycidyl 3-nitrobenzenesulfonate 
tisfically significant differences were established and 1-naphthol or 4-nitrophenol respectively as 
between isomers for half of the compounds tested, the reagents. The naphthyl ethers were obtained 
The goals of the present study are to conduct as oils with the (R)-isomer, [a]~ - 16.4 ° (C 2, 
an investigation of genotoxicity of the new enan- CHC13) and the (S)-isomer, [a ]~  + 17.3 ° (C 2, 
tiomeric epoxide reagents in comparison to the CHC13) having enantiomeric excess (%ee) of 92 
optical isomers of the established genotoxic corn- and 93 respectively. Recrystallization of the nitro- 
pounds, styrene oxide, glycidol and epichlorohy- phenyl ethers from methanol gave the (R)-iso- 
drin, as well as to determine whether there are mer, [ a ] ~ -  5.1 ° (C 0.5, CHCI 3) and (S)-isomer, 
differences between isomers in genotoxicity both [a]~  + 4.9 ° (C 0.6, CHC13) each with %ee >/98. 
in vitro and in vivo. We have also synthesized the The epoxides were considered suitable for geno- 
(R)-and (S)-isomers of glycidyl 1-naphthyl ether toxicity testing only when a sample (2 tzl, 10% 
as well as those of glycidyl 4-nitrophenyl ether so CH2C12 solution) showed a single homogeneous 
that these compounds, whose genotoxicity has spot after silica gel thin-layer chromatography 
previously been studied in our laboratories as (ethyl acetate/hexane) under UV observation and 
their racemates (Gift et al., 1989; 1990), could be after alkylation of 4-(4-nitrobenzyl)pyridine 
compared as their optical isomers. Similar to (Hammock et al., 1974). 
benzyloxymethyloxirane, these glycidyl ethers 
would have nucleophilic attack on C-3 (ring open- Mutagenicity assays 
ing) as the predominant mode of reaction. The Compounds dissolved in DMSO were tested 
short-term tests used in these evaluations are the for dose-mutagenicity relationships using Salmo- 
Ames test with Salmonella strain TA100 and nella typhimurium strain TA100 kindly provided 
chromosomal aberrations (CA) as well as SCE by Dr. Bruce Ames (University of California, 
tests in the bone-marrow cells of mice following Berkeley, CA). As epoxides are direct acting mu- 
intraperitoneal (ip) administration of the epox- tagens, the plate incorporation assay without 
ides. Thus, as suggested by Natarajan and Obe metabolic activation as described by Maron and 
(1986) and Shelby (1988) for screening of com- Ames (1983) was used. Plates were scored with 
pounds for genotoxicity, the detection of point an automatic counter (Autocount, Dynatech Labs, 
mutations by the widely used Ames bacterial test Chantilly, VA) which had been calibrated against 
is supplemented by in vivo evaluations that re- manually scored plates. Each dose was run in 
spond to strand breaks, triplicate and the dose-response relationship con- 
firmed in a second set of tests. Slopes were deter- 
Materials and methods mined from the combined data. 
Test compounds In vivo tests of bone-marrow cells 
The isomers, with the exception of 4 and 7, Male CD1 mice (10-12 weeks old, ~ 30 g) 
listed in Table 1 and 7,12-dimethylbenz[a]anthra- were purchased from Charles River Breeding 
cene (DMBA) were purchased from Aldrich Laboratories (Wilmington, MA). They were kept 
Chemical Co. (Milwaukee, WI). The optical rota- 4 per cage, fed chow (Purina) with water ad 
21)2 
libitum and housed 4-5 days prior to the start of toxicity, as measured by mitotic or replicative 
the experiments. Epoxides (100 mg/kg) in DMSO indices, but high enough to obtain a usable range 
(2 ml /kg)  which had been administered by ip of comparative response. DMBA in DMSO (2 
injection were evaluated for CA and SCE re- ml /kg)  was used as a positive control at 100 
sponses in bone-marrow cells. CA and SCE tests mg/kg for CA and at 50 mg/kg for SCE. A 
were conducted for 4 animals in each procedure response time of 24 h following the injection of 
for each isomer by our previously described pro- test compounds was used for CA where many 
t o c o l s  ( G i r i  e t  al., 1989).  F o r  C A ,  100 m e t a p h a s e  s e c o n d - d i v i s i o n  ce l l s  w o u l d  b e  p r e s e n t  b u t  w h e r e  
a n d  f o r  S C E ,  30 s e c o n d - d i v i s i o n  ce l l s  w e r e  s c o r e d  in  o u r  e x p e r i e n c e  t r i c h l o r o p r o p y l e n e  o x i d e ,  a n  
p e r  a n i m a l .  T h e  d o s e  o f  100 m g / k g  w a s  b a s e d  e p o x i d e  w i t h  a s h o r t  ha l f - l i f e ,  s h o w e d  n o  d i f f e r -  
u p o n  o u r  p r e v i o u s  e p o x i d e  s t u d i e s  ( G i r i  e t  al.,  e n c e s  f o r  t h e  s h o r t e r  r e s p o n s e  t i m e s  d i s c u s s e d  by  
1989; 1990)  to  a v o i d  a c u t e  t ox i c i t y  a n d  l imi t  cel l  P r e s t o n  e t  al. (1987) .  
TABLE 3 
IN VIVO CHROMOSOMAL ABERRATIONS INDUCED BY EPOXIDE R AND S ISOMERS AT 100 mg/kg  
Chemical Gaps a Aberrations/cell  Aberrant cells (%) b Mitotic indices (%) 
Chromatid Chromosome (mean + S.D.) c (mean _+ S.D.) c 
type type 
Solvent control 
DMSO (2 ml /kg)  3.00 0.010 0.000 1.00 + 0.82 3.51 +- 0.30 
Benzyloxymethyl- R 2.50 0.025 0.003 2.75 +- 0.50 * * 2.65 _+ 0.15 * * 
oxirane S 3.25 0.030 0.003 3.25 +- 0.96 * * 2.60 _+ 0.35 * * 
Epichlorohydrin R 2.75 0.028 0.000 2.75 _+ 0.50 * * 2.67 +- 0.23 * * 
S 2.75 0.025 0.000 2.50+0.58 * 2.66+_0.35 ** 
Glycidol R 5.75 0.035 0.000 3.50_+ 1.00 ** 2.58+_0.42 ** 
S 6.50 0.045 0.000 4.50 +_ 1.29 * * 1.82 +_ 0.14 * * 
Glycidyl 1-naphthyl R 3.50 0.033 0.003 3.50+_0.577 ** 2.30_+0.489 ** 
ether S 4.75 0.040 0.008 4.75 +- 0.957 * * 2.11 +- 0.495 * * 
Glycidyl 3-nitro- R 3.25 0.018 0.000 1.75_+0.50 2.59+0.24 ** 
benzenesulfonate S 1.75 0.018 0.000 1.75_+0.50 2.89+0.37 * 
Glycidyl 4-nitro- R 5.75 0.030 0.008 3.75+0.96 ** 2.90+_0.30 * 
benzoate S 4.75 0.050 0.005 5.50 +- 0.58 * * d 2.73 +_ 0.10 * * 
Glycidyl 4-nitro- R 3.00 0.035 0.000 3.50 +_ 1.000 * * 2.59 +_ 0.458 * * 
phenyl ether S 2.75 0.035 0.000 3.50 +- 0.577 * * 2.61 +_ 0.459 * * 
Glycidyl tosylate R 2.25 0.013 0.000 1.25+_0.50 2.74+0.17 ** 
S 2.75 0.013 0.000 1.25 +_ 0.50 2.78 +_ 0.27 * * 
Styrene oxide R 3.50 0.018 0.000 1.75 +_ 0.96 2.74 +_ 0.28 * * 
S 4.50 0.028 0.000 2.75 _+ 0.50 * * 2.58 + 0.22 * * 
Positive control 
DMBA 11.25 0.115 0.023 13.25 +_ 0.96 * * 2.13 +_ 0.12 * * 
Total chromatid and chromosome gaps at each concentration per 100 cells were recorded but not included as aberrations. 
b Cells with at least 1 aberration for 4 animals. 
c Results were compared to those of the control using Dunnett 's  test, where statistically significant differences are indicated by 
• P < 0 . 0 5  a n d * * P < 0 . 0 1 .  
d The (R)- and (S)-results were significantly different, where P < 0.05. 
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Results and discussion the isomers of the established genotoxic com- 
pounds epiehlorohydrin and styrene oxide but 
Mutagenicity results are summarized in Table somewhat less than that of glycidol. All the other 
2 and show that dose-response relationships could new reagents exhibited mutagenicities greater 
be established for each isomer. There are signifi- than that of these established genotoxic corn- 
cant differences (p  < 0.01) between isomers for pounds. These in vitro Salmonella results differ 
all the pairs of compounds in Table 2. The (S)- with those for the pairs of isomers tested in 
isomers for the benzyl ether, nitrobenzenesul- common with the in vitro Chinese hamster cell 
fonate, the nitrobenzoate and tosylate show study of von der Hude et al. (1992). In their 
greater mutagenicity than their (R)-isomers as study, no difference was established between the 
measured by revertants per/~mol. However, the glycidol nor styrene oxide isomers and the (R)- 
opposite is true for epichlorohydrin, glycidol, gly- glycidyl 4-nitrobenzoate was more genotoxic than 
cidyl 1-naphthyl ether, glycidyl 4-nitrophenyl ether its (S)-isomer. 
and styrene oxide. The benzyloxymethyloxirane The in vivo CA results are summarized in 
isomers had mutagenicity values comparable to Table 3 where the solvent, DMSO, is the negative 
T A B L E  4 
IN  V I V O  S I S T E R - C H R O M A T I D  E X C H A N G E S  I N D U C E D  BY E P O X I D E  R A N D  S I S O M E R S  A T  100 mg/kg 
Chemical SCE/cell  of 4 animals SCE/cell  Replicative indices 
(mean ± S.D.) " (mean  + S.D.) 
Solvent control 
D M S O  (2 m l / k g )  3.50 2.90 3.80 4.00 3.55 + 0.48 1.86 ± 0.06 
Benzyloxymethyl- R 4.50 4.70 4.27 3.87 4.34 _+ 0.36 * 1.85 + 0.06 
oxirane S 4.10 4.50 5.27 4.70 4.64 _+ 0.49 * * 1.84 + 0.03 
Epichlorohydrin R 4.87 4.40 5.23 5.43 4.98 _+ 0.45 * * 1.82 +_ 0.05 
S 3.57 3.27 3.83 4.30 3.74 + 0.44 b 1.85 ± 0.07 
Glycidol  R 7.53 8.10 7.96 7.90 7.87 ± 0.24 * * 1.83 ± 0.06 
S 10.73 11.07 9.03 9.83 10 .17±0 .92  **  b 1 .74±0 .05  
Glycidyl 1-naphthyl R 6.80 6.33 6.60 6.60 6.58 ± 0.19 * * 1.83 ± 0.04 
ether S 7.47 6.87 7.87 8.40 7.65 ± 0.65 * * c 1.81 ± 0.03 
Glycidyl 3-nitro- R 4.63 4.67 4.50 4.33 4.56 ± 0.11 * * 1.81 ± 0.05 
benzenesulfonate S 4.50 5.83 5.90 5.30 5.38 ± 0.65 * * c 1.83 ± 0.04 
Glycidyl 4-nitro- R 6.77 6.70 7.93 7.30 7.18 ± 0.57 * * 1.83 _+ 0.05 
benzoate S 10.00 8.30 8.67 9.73 9.18 _+ 0.82 * * b 1.81 ± 0.04 
Glycidyl 4-nitro- R 6.40 5.06 4.43 4.97 5.22 ± 0.84 * * 1.84 ± 0.03 
phenyl ether S 5.53 5.83 5.10 6.17 5 .66±0 .45  * * 1 .82±0 .04  
Glycidyl tosyla te  R 4.50 4.03 4.73 3.50 4.19 ± 0.55 1.84 ± 0.04 
S 4.93 6.67 5.60 4.73 5.48 ± 0.88 * * c 1.81 ± 0.06 
Styrene oxide R 3.60 3.63 3.30 3.90 3.61 ± 0.25 1.85 _+ 0.05 
S 5.68 4.63 4.73 5.23 5.06 ± 0.49 * * b 1.81 _+ 0.05 
Positive control 
D M B A  (50 m g / k g )  14.2 16.4 14.8 15.2 15.15 ± 0.93 * * 1.79 ± 0.03 
a M e a n ± S . D .  for 4 animals (30 cells/animal). Results at each concentration were compared to those of the control using 
Dunnett's test, where statistically significant differences are indicated by * P < 0.05 and **  P < 0.01. 
b The  (R)- and (S)-results were significantly different, where P < 0.01. 
c Same as above, where P < 0.05. 
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control and DMBA is the positive control. With not including those of epichlorohydrin, the (S)- 
the exception of the (R)- and (S)-isomers of gly- isomer was more genotoxic than the (R)-isomer. 
cidyl 3-nitrobenzenesulfonate and glycidyl tosy- The results outlined in Tables 2 -4  and the 
late as well as (R)-styrene oxide, there are statis- discussion above are summarized in Fig. 1 where 
tically significant differences in CA results com- the differences among the epoxides and between 
pared to the negative control. There are also the enantiomers are presented for the three 
significant decreases in mitotic index for all the short-term tests. The CA and SCE evaluations 
compounds tested, indicating toxicity to bone- follow a similar pattern of results across corn- 
marrow cells at the 100 mg /kg  dose. The CA pounds and in regard to the relative genotoxicity 
values for every epoxide isomer were significantly between (S)- and (R)-isomers. However, the 
lower than the strongly genotoxic positive control, greater sensitivity of the SCE test over that of CA 
DMBA. The CA results for the (S)-glycidyl 4- and its increased ability to detect differences 
nitrobenzoate and (S)-glycidyl 1-naphthyl ether between optical isomers is evident in this figure. 
are comparable. This latter epoxide, previously While there is general agreement between the in 
tested as a racemate, was the most genotoxic vitro Salmonella mutagenicity and the in vivo 
compound of a group of four epoxides selected results as to relative genotoxicity between (R)- 
for in vivo evaluation because of their demon- and (S)-isomers for a given pair of compounds, 
strated high mutagenicity in vitro (Giri et al., the in vitro results were not predictive of relative 
1989; 1990). While in general it was not possible in vivo genotoxicity among different pairs of com- 
to determine differences between optical isomers pounds. For example, the relatively low muta- 
based upon our current results, a significant (p  < genici ty for  the benzy loxyme thy lox i r ane ,  
0.05) difference was established for the 4-nitro- epichlorohydrin and styrene oxide isomers was 
benzoate isomers, with the (S)-isomer having the not predictive of their moderate genotoxicity in 
greater genotoxicity, vivo. The most notable difference between in 
SCE results are summarized in Table 4. As vitro and in vivo results is for the glycidol iso- 
was true for the CA results, all the epoxides were mers, where the Salmonella mutagenicity tests 
much less genotoxic than the positive control were neither predictive of the greater genotoxic- 
DMBA which was evaluated at half of the dose ity for the (S)-isomer vs. the (R)-isomer in vivo 
used for the epoxides. Except for 3 isomers, (S)- nor of the relatively high genotoxicity in vivo for 
epichlorohydrin, (R)-glycidyl tosylate and (R)- both isomers in contrast to the other pairs of 
styrene oxide, a difference in genotoxicity was compounds. The 4-nitrobenzoates were designed 
detected for all compounds, at least at the p < to hydrolyze faster than ring opening could occur 
0.05 level, when compared to the negative con- so that such esters would have functional equiva- 
trol. The glycidol and glycidyl 4-nitrobenzoate lency to glycidol (Ko et al., 1987). This being the 
isomers were distinctly more genotoxic than the case, then the comparable in vivo genotoxicity for 
other commercially available reagents. This geno- the benzoate and glycidol isomers could be ex- 
toxicity was only approached by the SCE re- plained on the basis of the esters reaching bone- 
sponses for our synthesized (R)- and (S)-isomers marrow cells as glycidol. This is in contrast to the 
of glycidyl 1-naphthyl ether. Only for the (S)- comparison of the in vitro mutagenicities of these 
glycidol was there a significant (p  < 0.05) de- esters and glycidol isomers where the former 
crease in cell replication kinetics which indicates isomers have much greater activity than the lat- 
toxicity to cell division. SCE evaluations proved ter. This would be consistent with much less 
to be more sensitive in determining differences opportunity for hydrolysis to occur on the 
between the (R)- and (S)-isomers than CA mea- Salmonella test plates than in vivo, so that in 
surements. Except for the benzyloxymethyloxi- vitro in contrast to in vivo, non-equivalent muta- 
rane and glycidyl 4-nitrophenyl ether isomers, gens are being compared. 
significant differences were established between In their applications as organic reagents, the 
optical isomers. For all these pairs of isomers, but glycidyl sulfonates react under basic conditions 
2(16 
with nucleophiles to displace the sulfonate groups racemic glycidol and related 2,3-epoxy alcohols, Chem. 
(Hanson, 1991). It is possible in biological systems Rev., 91,436-475. 
that these esters could react with w a t e r  to  yield Hiratsuka, A., A. Yokoi, H.Iwata, T. Watabe, K. Satoh, 1. 
Hatyama and K. Sato (1989) Glutathione conjugation of 
glycidol. It is apparent,  however, that while in styrene 7,8-oxide enantiomers by major glutathione trans- 
vivo conversion to glycidol might contribute to ferase isoenzymes isolated from rat livers, Biochem. Phar- 
the genotoxicity of these compounds, it can not macol., 38, 4405-4413. 
be as important as is the conversion of the ben- Klunder, J.M., T. Onami and K.B. Sharpless (1989) Arenesul- 
fonate derivatives of homochiral glycidol: Versatile chiral 
z o a t e s  to  glycidol since the levels of genotoxicity building blocks for organic synthesis, J. Org. Chem., 54, 
for the sulfonates do not match those of glycidol. 1295-1304. 
It also follows that differences in genotoxicity Ko, S.Y., H. Masamune and K.B. Sharpless (1987) p-Nitro- 
are due to substituent effects in addition to those benzoate esters of epoxy alcohols: Convenient synthons for 
water-soluble epoxy alcolols, J. Org. Chem., 52, 667-671. contributing to the route of reaction. For exam- 
ple, for the isomers of compounds 1, 3, 4 and 7 in Maron, D.M., and B.N. Ames (1983) Revised methods for the 
Salmonella mutagenicity test, Mutation Res., 113, 173-215. 
Fig. 1, which can only alkylate bionucleophiles McClure, D.E., B.H. Arison and J.J. Baldwin (1979) Mode of 
through ring opening at carbon 3, there are deft- nucleophilic addition to epichlorohydrin and related 
nite differences in the patterns of genotoxicity, species: chiral aryloxymethyloxiranes, J. Amer. Chem. Soc., 
Thus, the literature information concerning 101, 3666-3668. 
Natarajan, A.T., and G. Obe (1986) How do in vivo mam- 
differences in the mutagenicity between e n a n -  malian assays compare to in vitro assays in their ability to 
tiomeric aliphatic epoxides has been extended to detect mutations?, Mutation Res., 167, 189-201. 
a n e w  group of compounds and has been estab- Pagano, D.A., B. Yagen, O. Hernandez, J.R. Bend and E. 
lished in vivo. Differences in the patterns of Zeiger(1982) Mutagenicity of (R) and (S) styrene 7,8-oxide 
genotoxicity of the 3 short-term tests employed and the intermediary mercapturic acid metabolites formed 
from styrene 7,8-oxide, Environ. Mutagen., 4, 575-584. 
for our compounds could to a limited degree be Prelog, V., and G. Helmchen (1982) Basic principles of the 
related to their differences in chemical reaction CIP-system and proposals for a revision, Angew. Chem. 
pathways. Int. Ed. Engl., 21,567-583. 
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